- 专利标题： DEPOT SYSTEM COMPRISING GLATIRAMER ACETATE
-
申请号： EP18205308.2申请日： 2010-08-19
-
公开(公告)号： EP3536333A1公开(公告)日： 2019-09-11
- 发明人: MAROM, Ehud , RUBNOV, Shai
- 申请人： Mapi Pharma Ltd.
- 申请人地址： 16 Einstein Street Weizmann Science Park P.O. Box 4113 74140 Ness Ziona IL
- 专利权人： Mapi Pharma Ltd.
- 当前专利权人： Mapi Pharma Ltd.
- 当前专利权人地址： 16 Einstein Street Weizmann Science Park P.O. Box 4113 74140 Ness Ziona IL
- 代理机构： Vossius & Partner Patentanwälte Rechtsanwälte mbB
- 优先权： US29192810P 20100104
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61P25/00
摘要：
The present invention provides long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection.
公开/授权文献
- EP3536333B1 DEPOT SYSTEM COMPRISING GLATIRAMER ACETATE 公开/授权日：2022-08-03
信息查询
IPC分类:
